China's Top Future Healthcare Company Valued at RMB 55.3 Billion Tops 2018 VB100 List

From December 18 to 19, 2018, the VCBeat “2018 Top 100 Future Healthcare Companies” Forum was grandly held at the Renaissance Beijing Capital Hotel. More than 2,500 elites from the health and medical industry, both domestic and international, gathered for this prestigious event.

On the 18th, VCBeat grandly released the four main lists of the “2018 Top 100 Future Healthcare Companies”: “Top 100 Chinese Healthcare Companies,” “Top 100 Chinese Pharmaceutical Companies,” “Top 30 Chinese Health Companies,” and “Top 100 Overseas Companies.”

Furthermore, since 2018, VCBeat has added sub-rankings (Top 5) for specialized sectors (including 12 areas such as rehabilitation robotics, DTP pharmacies, and third-party medical services), as well as the “China Ranking: Top 10 Industrial Parks” and “China Ranking: Top 10 New Industry Cities.”

Living in a grand era defined by the exploration of future healthcare’s “trends,” we anticipate new technological breakthroughs and innovations, as well as the exploration and refinement of models, to bring greater promise to the future of human health.

As an observer and recorder of the industry, VCBeat aims to examine social transformation, economic fluctuations, and consumption evolution from both Chinese and global perspectives, thereby identifying the direction of change in the healthcare industry through a broader lens. The “Top 100 Future Healthcare Companies” initiative seeks to select Chinese innovative healthcare enterprises that truly represent the future of medicine, uncover the core forces driving China’s future healthcare industry, and promote innovation and transformation within the healthcare sector.

In 2018, the “Top 100 Future Healthcare Companies” list was compiled through a three-stage process of preliminary selection, review, and final approval, identifying the most promising enterprises across various sub-sectors of the healthcare industry. The list aims to set benchmarks for innovative companies, provide guidance for investment institutions, and deliver value to its audience.

The list of companies on the 2018 “Top 100 Future Healthcare Companies” China Healthcare Ranking is as follows:

The list of companies on the 2018 “Top 100 Future Healthcare Companies” China Pharmaceutical Ranking is as follows:

The following is the list of companies on the 2018 “Top 100 Future Healthcare Companies” China Health Ranking:

The list of companies on the 2018 “Top 100 Future Healthcare Companies” Overseas List is as follows:

The “2018 Future Healthcare Industry Report,” released by VCBeat and VCBeat Research Institute, points out that 2018 was a year of transformation in the healthcare sector, with China achieving a series of accomplishments in its reforms. Healthcare service capacity has been strengthened, public health service capabilities improved, management of medical institutions gradually standardized, coverage of medical insurance services further expanded, regulatory support for innovative drugs continuously intensified, and healthcare-related innovative technologies emerging one after another...

Driven by a multitude of factors, a cohort of high-profile companies has emerged across various sub-sectors of medical innovation. Whether they are traditional enterprises committed to bold reform or startups forging ahead with determination, these organizations have become the most vocal players in the healthcare innovation landscape.

“Top 100 Future Healthcare Companies” 2018 Annual Awards were determined through voting by a publicly selected panel of judges comprising industry experts, investors, and policy researchers. The final awards, including sub-sector rankings for the “Top 100 Future Healthcare Companies,” the Emerging Cities Ranking, and the Industrial Park Ranking, were jointly evaluated and announced by the VCBeat Content Center, VBInsight, and the industry judging panel.

The sub-sector rankings include twelve major categories: “Rehabilitation Robotics,” “DTP Pharmacies,” “Third-Party Medical Services,” “Medical Internet of Things (IoMT),” “Pediatric Clinics,” “Physician Groups,” “Digital Traditional Chinese Medicine (TCM),” “Digital Pharmacy Equipment,” “Insurance Payment,” “Consumer Genomics,” “Gene Editing,” and “Microbiome.”The list is as follows:

As another key factor driving corporate growth, cities and industrial parks have also documented the dynamic and transformative evolution of the health sector in this new era defined by emerging trends in future healthcare.

2018 Future Healthcare Top 100 · China ListIndustrial Park Ranking/Industrial New City RankingThe list is as follows: